• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量淀粉样蛋白和tau蛋白PET成像定量准确性的研究。

Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging.

作者信息

Nai Ying-Hwey, Watanuki Shoichi, Tashiro Manabu, Okamura Nobuyuki, Watabe Hiroshi

机构信息

Division of Radiation Informatics for Medical Imaging, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.

Division of Radiation Protection and Safety Control, Cyclotron and Radioisotope Center (CYRIC), Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.

出版信息

Radiol Phys Technol. 2018 Dec;11(4):451-459. doi: 10.1007/s12194-018-0485-y. Epub 2018 Oct 16.

DOI:10.1007/s12194-018-0485-y
PMID:30328073
Abstract

With the increasing incidence of dementia worldwide, the frequent use of amyloid and tau positron emission tomography imaging requires low-dose protocols for the differential diagnoses of various neurodegenerative diseases and the monitoring of disease progression. In this study, we investigated the feasibility to reduce the PET dose without a significant loss of quantitative accuracy in 3D dynamic row action maximum likelihood algorithm-reconstructed PET images using [C]PIB and [F]THK5351. Eighteen cognitively normal young controls, cognitively normal elderly controls, and patients with probable Alzheimer's disease (n = 6 each), were included. Reduced doses were simulated by randomly sampling half and quarter of the full counts in list mode data for one independent realization at each simulated dose. Bias was evaluated between the reduced dose from the full dose of standardized uptake value ratio (SUVR), distribution volume ratio (DVR) from reference Logan, and non-displaceable binding potential (BP) from simplified reference tissue model (SRTM). DVR yielded the least bias at low dose compared to SUVR and BP, and thus, is highly recommended. The dose of [F]THK5351 and [C]PIB can be reduced to a quarter of the full dose using DVR for evaluation, whereas the dose can only be reduced to half and a quarter of the full dose for [F]THK5351 and [C]PIB using SUVR. BP showed inconsistent trend and large bias at low dose. The feasibility of dose reduction was dependent on the selected parameters of interest, reconstruction algorithms, reference regions, and to a lesser degree by motion effects.

摘要

随着全球痴呆症发病率的上升,淀粉样蛋白和tau正电子发射断层扫描成像的频繁使用需要低剂量方案来鉴别各种神经退行性疾病并监测疾病进展。在本研究中,我们使用[C]PIB和[F]THK5351,研究了在三维动态行动作最大似然算法重建的PET图像中降低PET剂量而不显著损失定量准确性的可行性。纳入了18名认知正常的年轻对照者、认知正常的老年对照者以及可能患有阿尔茨海默病的患者(每组n = 6)。通过在列表模式数据中随机抽取全计数的一半和四分之一来模拟降低剂量,以在每个模拟剂量下进行一次独立实现。评估了全剂量标准化摄取值比率(SUVR)、参考洛根分布容积比率(DVR)以及简化参考组织模型(SRTM)的不可置换结合潜力(BP)与降低剂量之间的偏差。与SUVR和BP相比,DVR在低剂量时产生的偏差最小,因此强烈推荐使用。使用DVR进行评估时,[F]THK5351和[C]PIB的剂量可降低至全剂量的四分之一,而使用SUVR时,[F]THK5351和[C]PIB的剂量只能分别降低至全剂量的一半和四分之一。BP在低剂量时显示出不一致的趋势和较大偏差。剂量降低的可行性取决于所选的感兴趣参数、重建算法、参考区域,并且在较小程度上取决于运动效应。

相似文献

1
Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging.低剂量淀粉样蛋白和tau蛋白PET成像定量准确性的研究。
Radiol Phys Technol. 2018 Dec;11(4):451-459. doi: 10.1007/s12194-018-0485-y. Epub 2018 Oct 16.
2
Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.(S)-¹⁸F-THK5117 作为评估 Tau 病理学的 PET 示踪剂的示踪动力学分析。
J Nucl Med. 2016 Apr;57(4):574-81. doi: 10.2967/jnumed.115.158519. Epub 2016 Jan 21.
3
Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.使用[18F]THK - 5351对认知正常的老年人和阿尔茨海默病患者中tau蛋白积累的动态PET测量。
PLoS One. 2016 Jun 29;11(6):e0158460. doi: 10.1371/journal.pone.0158460. eCollection 2016.
4
A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [F]THK5351 and [C]PIB.使用[F]THK5351和[C]PIB对Tau和淀粉样蛋白PET成像的五种部分容积校正方法的比较。
Ann Nucl Med. 2017 Aug;31(7):563-569. doi: 10.1007/s12149-017-1185-0. Epub 2017 Jun 21.
5
Head to head comparison of [F] AV-1451 and [F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.比较 [F] AV-1451 和 [F] THK5351 在阿尔茨海默病和额颞叶痴呆中的 tau 成像。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):432-442. doi: 10.1007/s00259-017-3876-0. Epub 2017 Nov 16.
6
In Vivo Comparison of Tau Radioligands F-THK-5351 and F-THK-5317.Tau放射性配体F-THK-5351和F-THK-5317的体内比较
J Nucl Med. 2017 Jun;58(6):996-1002. doi: 10.2967/jnumed.116.182980. Epub 2016 Nov 10.
7
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls.在体鉴定和定量研究人类神经纤维缠结 Tau PET 放射性配体 F-MK-6240 从阿尔茨海默病痴呆到年轻对照的变化。
J Nucl Med. 2019 Jan;60(1):93-99. doi: 10.2967/jnumed.118.209650. Epub 2018 May 18.
8
Monoamine oxidase B inhibitor, selegiline, reduces F-THK5351 uptake in the human brain.单胺氧化酶B抑制剂司来吉兰可降低人脑中F-THK5351的摄取。
Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y.
9
Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.基于参考组织的18F-AV-1451用于tau成像的动力学评估
J Nucl Med. 2017 Feb;58(2):332-338. doi: 10.2967/jnumed.116.175273. Epub 2016 Sep 1.
10
Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.使用T1加权/T2加权磁共振比率来阐明认知正常受试者中由于β淀粉样蛋白积累所导致的变化。
Neuroimage Clin. 2016 Dec 2;13:209-214. doi: 10.1016/j.nicl.2016.11.029. eCollection 2017.

引用本文的文献

1
Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.数字探测器PET/CT增加了阿尔茨海默病中淀粉样蛋白的百分制测量值:相机的直接比较。
J Alzheimers Dis. 2025 Feb;103(4):1257-1268. doi: 10.1177/13872877241313063. Epub 2025 Jan 26.
2
Comparison of the performances of machine learning and deep learning in improving the quality of low dose lung cancer PET images.机器学习和深度学习在提高低剂量肺癌 PET 图像质量方面的性能比较。
Jpn J Radiol. 2022 Dec;40(12):1290-1299. doi: 10.1007/s11604-022-01311-z. Epub 2022 Jul 9.

本文引用的文献

1
Validation of true low-dose F-FDG PET of the brain.脑部真正低剂量F-FDG PET的验证
Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):269-276. eCollection 2016.
2
Validation of a simplified scatter correction method for 3D brain PET with O.用于含氧15的三维脑部正电子发射断层扫描(PET)的简化散射校正方法的验证
Ann Nucl Med. 2016 Dec;30(10):690-698. doi: 10.1007/s12149-016-1114-7. Epub 2016 Aug 17.
3
Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature.
PET/CT检查中氟脱氧葡萄糖摄取量低的恶性肿瘤:陷阱与预后重要性:住院医师和进修医师教育专题
Radiographics. 2016 Jan-Feb;36(1):293-4. doi: 10.1148/rg.2016150073.
4
Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging.降低放射性核素心肌灌注显像辐射剂量的方法。
J Nucl Med. 2015 Apr;56(4):592-9. doi: 10.2967/jnumed.112.115097. Epub 2015 Mar 12.
5
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.通过脑白质参考区域增强纵向淀粉样蛋白β正电子发射断层扫描(PET)变化特征描述及评估淀粉样蛋白修饰治疗的效能。
J Nucl Med. 2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5.
6
Amyloid PET imaging: applications beyond Alzheimer's disease.淀粉样蛋白PET成像:阿尔茨海默病之外的应用
Clin Transl Imaging. 2015;3(1):39-55. doi: 10.1007/s40336-014-0098-3. Epub 2015 Jan 21.
7
Tau imaging: early progress and future directions.tau 成像:早期进展与未来方向。
Lancet Neurol. 2015 Jan;14(1):114-24. doi: 10.1016/S1474-4422(14)70252-2.
8
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.阿尔茨海默病的淀粉样蛋白 PET 成像:三种放射性示踪剂的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20.
9
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.神经退行性疾病中致病性蛋白聚集物的自我传播。
Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481.
10
Optimal relaxation parameters of DRAMA (dynamic RAMLA) aiming at one-pass image reconstruction for 3D-PET.旨在用于 3D-PET 单次扫描图像重建的 DRAMA(动态 RAMLA)的最佳弛豫参数。
Phys Med Biol. 2010 May 21;55(10):2917-39. doi: 10.1088/0031-9155/55/10/009. Epub 2010 Apr 30.